BioFire Diagnostics Respiratory Panel 2.1 plus (RP2.1plus)

Land: Singapur

Sprache: Englisch

Quelle: HSA (Health Sciences Authority)

Verfügbar ab:

BIOMERIEUX SINGAPORE PTE. LTD.

Klasse:

Class D IVD

Hergestellt von:

BioFire Diagnostics, LLC

Therapiebereich:

Microbiology

Anwendungsgebiete:

The BioFire Respiratory Panel 2.1 plus (RP2.1plus) is a PCR- based multiplexed nucleic acid test intended for use with the BioFire FilmArray® 2.0 or BioFire FilmArray® Torch Systems for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections, including COVID-19. The following organism types and subtypes are identified using the BioFire RP2.1plus: Adenovirus, Coronavirus 229E, Coronavirus HKU1,Coronavirus NL63, Coronavirus OC43, MERS-CoV, SARS-CoV-2, Human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A virus including subtypes H1, H1-2009, and H3, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Respiratory Syncytial Virus, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma pneumonia.

Produktbesonderheiten:

Models: Biofire Respiratory Panel 2.1 plus (RP2.1 plus) - 423740, BioFire RP2.1plus Pouch Module Software - BioFire RP2.1plus Pouch Module Software

Berechtigungsdatum:

2022-12-22